Phosphatidylethanolamines
"Phosphatidylethanolamines" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Derivatives of phosphatidic acids in which the phosphoric acid is bound in ester linkage to an ethanolamine moiety. Complete hydrolysis yields 1 mole of glycerol, phosphoric acid and ethanolamine and 2 moles of fatty acids.
Descriptor ID |
D010714
|
MeSH Number(s) |
D10.570.755.375.760.400.840
|
Concept/Terms |
Phosphatidylethanolamines- Phosphatidylethanolamines
- Ethanolamineglycerophospholipids
- Cephalins
- Ethanolamine Phosphoglycerides
- Phosphoglycerides, Ethanolamine
|
Below are MeSH descriptors whose meaning is more general than "Phosphatidylethanolamines".
Below are MeSH descriptors whose meaning is more specific than "Phosphatidylethanolamines".
This graph shows the total number of publications written about "Phosphatidylethanolamines" by people in this website by year, and whether "Phosphatidylethanolamines" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 0 | 1 | 1 |
1998 | 1 | 0 | 1 |
2003 | 0 | 1 | 1 |
2006 | 0 | 2 | 2 |
2007 | 0 | 1 | 1 |
2009 | 0 | 1 | 1 |
2015 | 0 | 1 | 1 |
2021 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Phosphatidylethanolamines" by people in Profiles.
-
A Multifunctional Neutralizing Antibody-Conjugated Nanoparticle Inhibits and Inactivates SARS-CoV-2. Adv Sci (Weinh). 2022 01; 9(2):e2103240.
-
CHARMM-GUI Input Generator for NAMD, GROMACS, AMBER, OpenMM, and CHARMM/OpenMM Simulations Using the CHARMM36 Additive Force Field. J Chem Theory Comput. 2016 Jan 12; 12(1):405-13.
-
In vivo evaluation of paclitaxel-loaded lipid nanocapsules after intravenous and oral administration on resistant tumor. Nanomedicine (Lond). 2015 Mar; 10(4):589-601.
-
The parasitophorous vacuole membrane of Toxoplasma gondii is targeted for disruption by ubiquitin-like conjugation systems of autophagy. Immunity. 2014 Jun 19; 40(6):924-35.
-
In vivo imaging of DNA lipid nanocapsules after systemic administration in a melanoma mouse model. Int J Pharm. 2012 Feb 14; 423(1):108-15.
-
Development and characterization of immuno-nanocarriers targeting the cancer stem cell marker AC133. Int J Pharm. 2012 Feb 14; 423(1):93-101.
-
Administration-dependent efficacy of ferrociphenol lipid nanocapsules for the treatment of intracranial 9L rat gliosarcoma. Int J Pharm. 2012 Feb 14; 423(1):55-62.
-
CHARMM-GUI Membrane Builder for mixed bilayers and its application to yeast membranes. Biophys J. 2009 Jul 08; 97(1):50-8.
-
The encapsulation of DNA molecules within biomimetic lipid nanocapsules. Biomaterials. 2009 Jun; 30(18):3197-204.
-
The influence of headgroup structure and fatty acyl chain saturation of phospholipids on monolayer behavior: a comparative rheological study. Chem Phys Lipids. 2007 Dec; 150(2):167-75.